Literature DB >> 8497050

Characterization of a temperature-sensitive influenza B virus mutant defective in neuraminidase.

S Shibata1, F Yamamoto-Goshima, K Maeno, T Hanaichi, Y Fujita, K Nakajima, M Imai, T Komatsu, S Sugiura.   

Abstract

ts5, a temperature-sensitive mutant of influenza B virus, belongs to one of seven recombination groups. When the mutant infected MDCK cells at the nonpermissive temperature (37.5 degrees C), infectious virus was produced at very low levels compared with the yield at the permissive temperature (32 degrees C) and hemagglutinating and enzymatic activities were undetectable. However, viral protein synthesis and transport of hemagglutinin (HA) and neuraminidase (NA) to the cell surface were not affected. The NA was found as a monomer within cells even at 32 degrees C, in contrast to wild-type virus NA, existing mostly as an oligomer, but the mutant had oligomeric NA, like the wild-type virus. Its enzymatic activity was more thermolabile than that of wild-type virus. Despite the low yield, large aggregates of progeny virus particles were found to accumulate on the cell surface at the nonpermissive temperature, and these aggregates were broken by treatment with bacterial neuraminidase, with the concomitant appearance of hemagglutinating activity, suggesting that NA prevents the aggregation of progeny virus by removal of neuraminic acid from HA and cell receptor, allowing its release from the cells. Further treatment with trypsin resulted in the recovery of infectivity. When bacterial NA was added to the culture early in infection, many hemagglutinable infectious virus was produced. We also suggest that the removal of neuraminic acid from HA by NA is essential for the subsequent cleavage of HA by cellular protease. Nucleotide sequence analysis of RNA segment 6 revealed that ts5 encoded five amino acid changes in the NA molecule but not in NB.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8497050      PMCID: PMC237667          DOI: 10.1128/JVI.67.6.3264-3273.1993

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide.

Authors:  S G Lazarowitz; P W Choppin
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

2.  Neuraminidase: the specific enzyme of influenza virus and Vibrio cholerae.

Authors:  A GOTTSCHALK
Journal:  Biochim Biophys Acta       Date:  1957-03

3.  Activation of influenza A viruses by trypsin treatment.

Authors:  H D Klenk; R Rott; M Orlich; J Blödorn
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

4.  Analysis of the inhibitory effect of canavanine on the replication of influenza RI/5+ virus. I. Inhibition of assembly of RNP.

Authors:  K Maeno; S Yoshii; K Mita; M Hamaguchi; T Yoshida; M Iinuma; Y Nagai; T Matsumoto
Journal:  Virology       Date:  1979-04-15       Impact factor: 3.616

5.  Characterization of temperature sensitive influenza virus mutants defective in neuraminidase.

Authors:  P Palese; K Tobita; M Ueda; R W Compans
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

6.  Developmental sequence and intracellular sites of synthesis of three structural protein antigens of influenza A2 virus.

Authors:  K Maeno; E D Kilbourne
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

7.  Neurovirulence of influenza virus in mice. I. Neurovirulence of recombinants between virulent and avirulent virus strains.

Authors:  A Sugiura; M Ueda
Journal:  Virology       Date:  1980-03       Impact factor: 3.616

8.  Plaque formation by influenza B virus in a porcine kidney cell line.

Authors:  M Shibata; K Maeno; S Isomura; T Tsurumi; H Aoki; S Suzuki
Journal:  Microbiol Immunol       Date:  1982       Impact factor: 1.955

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells.

Authors:  J L Schulman; P Palese
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

View more
  14 in total

1.  Characterization of a live, attenuated human parainfluenza type 3 virus candidate vaccine strain.

Authors:  R Ray; K Meyer; F K Newman; R B Belshe
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

2.  Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection.

Authors:  Yosuke Maeda; Hiromi Terasawa; Yuetsu Tanaka; Chisho Mitsuura; Kaori Nakashima; Keisuke Yusa; Shinji Harada
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

3.  Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice.

Authors:  M T Hughes; M Matrosovich; M E Rodgers; M McGregor; Y Kawaoka
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Adaptation of influenza A viruses to cells expressing low levels of sialic acid leads to loss of neuraminidase activity.

Authors:  M T Hughes; M McGregor; T Suzuki; Y Suzuki; Y Kawaoka
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef.

Authors:  B K Chen; R T Gandhi; D Baltimore
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

6.  Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding.

Authors:  Subrata Barman; Lopa Adhikary; Alok K Chakrabarti; Carl Bernas; Yoshihiro Kawaoka; Debi P Nayak
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Temperature-sensitive phenotype of the human parainfluenza virus type 3 candidate vaccine strain (cp45) correlates with a defect in the L gene.

Authors:  R Ray; M S Galinski; B R Heminway; K Meyer; F K Newman; R B Belshe
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  Neuraminidase-producing oral mitis group streptococci potentially contribute to influenza viral infection and reduction in antiviral efficacy of zanamivir.

Authors:  Noriaki Kamio; Kenichi Imai; Kazufumi Shimizu; Marni E Cueno; Muneaki Tamura; Yuko Saito; Kuniyasu Ochiai
Journal:  Cell Mol Life Sci       Date:  2014-07-08       Impact factor: 9.261

9.  Role of neuraminidase in the morphogenesis of influenza B virus.

Authors:  F Yamamoto-Goshima; K Maeno; T Morishita; M Ueda; Y Fujita; K Nakajima; S Yoshii
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

10.  Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding.

Authors:  C Liu; M C Eichelberger; R W Compans; G M Air
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.